40 Participants Needed

Contingency Management for Substance Use During Pregnancy

(SUPPORT-MOM Trial)

Recruiting at 1 trial location
MM
JC
JK
Overseen ByJeannie Kelly, MD, MS
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Washington University School of Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests new methods to help pregnant individuals with substance use issues remain in treatment and support their recovery. The study explores two strategies: connecting participants with community resources such as housing and childcare, and using rewards to encourage positive behaviors, known as Contingency Management. It targets those who are pregnant or recently gave birth and have a history of substance use. By identifying the most effective strategies, the trial aims to improve health outcomes for both the parent and baby. As an unphased trial, this study provides a unique opportunity to contribute to innovative approaches that could significantly enhance recovery support for pregnant individuals.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that contingency management is generally safe for pregnant women with substance use issues. Studies have found that this method can help pregnant women quit using harmful substances without serious side effects. For instance, a Cochrane review found that contingency management was the most effective way to help pregnant women stop smoking. These studies reported no major safety concerns, suggesting that the treatment is well-tolerated. However, since everyone is different, discussing any concerns with a healthcare provider before joining a clinical trial is important.12345

Why are researchers excited about this trial?

Researchers are excited about Contingency Management for substance use during pregnancy because it offers a unique approach compared to traditional methods like counseling or medication-assisted treatments. This method uses positive reinforcement, such as providing rewards for healthy behaviors, which can help motivate individuals to reduce substance use. Additionally, integrating social drivers of health screening addresses external factors that may affect health, such as access to resources and social support, offering a more holistic approach to treatment. By targeting both behavior and social determinants, this approach has the potential to be more effective and supportive for pregnant individuals struggling with substance use.

What evidence suggests that this trial's treatments could be effective for substance use during pregnancy?

Research has shown that using rewards, a method known as Contingency Management, can help pregnant women reduce substance use. In this trial, participants will receive Contingency Management, which studies have shown makes women more than twice as likely to stop using substances compared to those who didn't receive rewards. One study demonstrated that using rewards increased the chances of obtaining expected drug test results and helped women remain substance-free for longer. In some cases, 83% of women stopped using at least one substance during pregnancy, although it often took more than four months to achieve this. Overall, using rewards appears to improve attendance at treatment sessions and increase the chances of staying substance-free.12567

Who Is on the Research Team?

AB

Ana Baumann Walker, PhD, MA

Principal Investigator

Washington University School of Medicine

JC

Jeannie C Kelly, MD, MS

Principal Investigator

Washington University School of Medicine

Are You a Good Fit for This Trial?

This trial is for pregnant individuals or those within three years postpartum, who are dealing with substance use disorder as defined by clinical standards. It aims to help them stay engaged in recovery services during and after pregnancy.

Inclusion Criteria

Confirmed viable intrauterine pregnancy at any gestational age, or within three years postpartum
SUD as defined in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders or clinician documentation

Exclusion Criteria

I choose not to have follow-up care at the study site.
I do not need immediate hospitalization for any unstable conditions.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Social Needs Screening and Referral

Implementation of a standardized social needs screening and referral protocol to connect patients with community-based supports

Up to 6 months postpartum
Regular visits as needed for screening and referrals

Contingency Management Intervention

Pilot testing of a contingency management framework to incentivize engagement in recovery-supportive behaviors

12 weeks
Weekly CM sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Contingency Management

Trial Overview

The study tests two strategies: a protocol for screening social needs and referring patients to community support, plus a contingency management program that rewards behaviors supporting recovery from substance use.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Social drivers of health screeningExperimental Treatment1 Intervention
Group II: Contingency ManagementExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Washington University School of Medicine

Lead Sponsor

Trials
2,027
Recruited
2,353,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

Citations

Contingency Management Interventions for Tobacco and ...

Our search strategy revealed 27 primary studies of CM in pregnancy. CM was effective in the majority of studies targeting nicotine abstinence, and results were ...

The effectiveness of incentives in enhancing treatment ...

This study examined the effectiveness of short-term contingency management for eliminating cocaine use and increasing full day treatment attendance with ...

Contingency Management in a Perinatal Substance ...

This study showed that CM was associated with more expected UDS results and a greater duration of abstinence, regardless of which other 2 ...

Substance Use During and After Pregnancy

During pregnancy, most women (83%) were able to become abstinent from at least one substance, although, on average, it took greater than four months to achieve ...

Contingency management interventions for abstinence from ...

Women assigned to incentive interventions were more than twice as likely to be abstinent compared with controls (RR=2.43, 95% CI 2.04-2.91) (Figure 2). Trials ...

Tobacco treatment incorporating contingency management ...

A 2017 Cochrane review cited high-quality evidence that contingency management was the most effective treatment for pregnant women when compared ...

Care for Pregnant and Postpartum Patients with Substance ...

In 2017, Louisiana's Pregnancy-Associated Mortality Review Report identified substance use as one of the leading causes of pregnancy-associated deaths among ...